Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The MORPHEUS programme brings together clinical, biological, morphological and socio-anthropological data from 14 French and European cohorts into one harmonized database. Using systematic literature review, cohort fusion and both quantitative and qualitative methods, the project will search for biomarkers that discriminate risk of thromboembolic recurrence, bleeding and mortality after venous thromboembolism. MC-MORPHEUS is the data-aggregation phase focused on identifying those predictive markers that will feed a time-dependent, multi-level prediction tool. That tool is intended to be integrated into shared medical decision-making and later validated in a randomized stepped-wedge cluster trial.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cohorts led by members of the European MORPHEUS project consortium European MORPHEUS project

Exclusion Criteria:

* Lack of consent in cohorts

Where it's running

• Chu Brest
  Brest, France Recruiting

Study contacts

• Study coordinator: Francis COUTURAUD
• Email: francis.couturaud@chu-brest.fr
• Phone: 298347348

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DoACs vs LMWH for blood flow after knee replacement

  This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.

  Recruiting Military Hospital of Tunis · Tunis, Tunis Governorate · NCT07869615

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Screening for blood clots in adults with acute heart failure

  This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.

  Recruiting University Hospital, Angers · Agen and 9 other locations · NCT07499661

• Blood test and software to guide treatment for venous thromboembolism

  This project tests whether a blood-based ctDNA test combined with a software risk score can predict if VTE will come back in adults with cancer-associated DVT or PE who have finished 3–12 months of anticoagulation.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT07399977

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

• Rosuvastatin to help prevent blood clots in cancer patients

  This study tests whether taking rosuvastatin daily for a year can lower the chance of dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t planned to receive blood-thinning medicine.

  Recruiting at 7 sites Phase 4 Brigham and Women's Hospital · Irvine, California and 8 other locations · NCT07303816

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.